Clinical Trial Update: Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With Nexavar

View source ↗

Summary

A completed clinical trial update describing patient characteristics in advanced renal cell carcinoma and the use of Nexavar (sorafenib) in daily practice.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Bayer | Conditions: Carcinoma, Renal Cell, Carcinoma, Renal Cell (Advanced) | Status: COMPLETED